首页> 外文期刊>The Cardiology >Myocardial Pharmacological Preconditioning by Norepinephrine in Rabbit. A Role for Beta-3 Adrenergic Agonists?
【24h】

Myocardial Pharmacological Preconditioning by Norepinephrine in Rabbit. A Role for Beta-3 Adrenergic Agonists?

机译:去甲肾上腺素对家兔的心肌药理预处理。 Beta-3肾上腺素激动剂的作用?

获取原文
       

摘要

High doses of norepinephrine abolish the infarct-limiting effect of Ischemic Preconditioning (IP) in rabbits. We wished to define the role of the beta-3 receptors in this observation. Rabbits were randomized into 5 groups of 8 animals each. In Control Group (CTRL), anaesthetized rabbits were subjected to 30 min left coronary marginal branch occlusion and 180 min reperfusion. In NEHI group, rabbits received a 10 ?g kg 1 norepinephrine injection 10 min before coronary occlusion and reperfusion. In NELOW group, rabbits received 0.25 ?g/kg/min of norepinephrine for 5 min and then had 10 min of washout before coronary occlusion and reperfusion. In NELOWBRL group, rabbits had BRL37344 (8.3 ?g kg 1) injection 1 min prior to a norepinephrine perfusion comparable to NELOW group, followed by ischemia and reperfusion. In BRL group, rabbits had BRL37344 (8.3 ?g kg 1) injection 10 min before coronary occlusion and reperfusion. At termination of the experiment, Left Ventricular Volume (LVV), myocardial Volume At Risk (VAR) and Infarct Volume (IV) were determined with methylene blue and tetrazolium staining and measured using planimetry. LVV was not significantly different among groups. Myocardial VAR/LVV was not significantly different between groups (CTRL, 13.52?5.17%; NEHI, 12.11?4.23%; NELOW, 12.45?11.35%; NELOWBRL, 14.71?4.74; BRL, 8.39?4.60; p = ns). IV/VAR was significantly reduced in the NELOW group as compared with CTRL, NEHI, NELOWBRL and BRL (respectively, 16.52?5.50% vs 56.42?14.40%, 55.71?8.38%, 50.95?11.62%, 50.18?10.20, p< 0.001). There was no significant difference in IV/VAR between CTRL, NEHI, NELOWBRL and BRL. The absence of a preconditioning protective effect during a massive injection of norepinephrine could be in relation with a beta-3 stimulation that interferes with the preconditioning pathways.
机译:高剂量的去甲肾上腺素消除了兔缺血预适应(IP)的梗塞限制作用。我们希望定义此观察中β-3受体的作用。将兔子随机分为5组,每组8只动物。在对照组(CTRL)中,对麻醉的兔子进行30分钟左冠状动脉边缘分支闭塞和180分钟再灌注。在NEHI组,兔子在冠状动脉闭塞和再灌注前10分钟接受10 µg kg 1 去甲肾上腺素注射。在NELOW组中,兔子接受0.25μg/ kg / min的去甲肾上腺素5分钟,然后在冠状动脉闭塞和再灌注之前进行10分钟的冲洗。 NELOWBRL组的兔子在去甲肾上腺素灌流前1分钟注射了BRL37344(8.3 µg kg 1 ),与NELOW组相当,然后进行了缺血和再灌注。在BRL组中,兔子在冠状动脉闭塞和再灌注前10分钟注射BRL37344(8.3 µg kg 1 )。在实验结束时,用亚甲基蓝和四唑鎓染色法测定左心室容积(LVV),有风险的心肌容积(VAR)和梗塞容积(IV),并用比色法测量。 LVV在各组之间无显着差异。各组之间的心肌VAR / LVV无显着差异(CTRL,13.52±5.17%; NEHI,12.11±4.23%; NELOW,12.45±11.35%; NELOWBRL,14.71±4.74; BRL,8.39±4.60; p = ns)。与CTRL,NEHI,NELOWBRL和BRL相比,NELOW组的IV / VAR显着降低(分别为16.52%5.50%和56.42%14.40%,55.71%8.38%,50.95%11.62%,50.18%10.20,p <0.001 )。 CTRL,NEHI,NELOWBRL和BRL之间的IV / VAR没有显着差异。在大量注射去甲肾上腺素期间缺乏预处理保护作用可能与干扰预处理路径的β-3刺激有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号